Quick Comparison
| Noopept | Phosphatidylserine | |
|---|---|---|
| Half-Life | 30-60 minutes (active metabolite cycloprolylglycine persists longer) | Not well-characterized orally; brain PS turns over slowly |
| Typical Dosage | Standard: 10-30 mg sublingually or orally, 2-3 times daily. Sublingual administration provides faster onset. Do not exceed 30 mg per dose. | Standard: 100-300 mg daily in 1-3 doses. Most studies use 300 mg daily. Soy-derived and sunflower-derived forms are both effective. Take with food for absorption. |
| Administration | Oral or sublingual (sublingual preferred for faster onset and higher bioavailability). Available as powder, capsules, or sublingual tablets. | Oral (softgels, capsules). Soy-derived or sunflower-derived. Take with fat for absorption. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Noopept
Noopept modulates AMPA and NMDA receptors similarly to racetams through positive allosteric modulation. Its key distinguishing feature is upregulation of BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) via activation of TrkB and TrkA receptor signaling cascades — these neurotrophins are essential for neuronal growth, survival, dendritic arborization, and synaptic plasticity. Noopept inhibits glutamate-induced excitotoxicity by reducing calcium influx through NMDA receptors and modulating the NR2B subunit. It activates the PI3K/Akt and MAPK/ERK pathways downstream of neurotrophin receptors. The active metabolite cycloprolylglycine (a cyclic dipeptide) has endogenous nootropic activity, potentially acting as a trace amine-associated receptor ligand. Neuroprotection is further mediated through antioxidant effects and mitochondrial stabilization.
Phosphatidylserine
PS is a structural component of neuronal membranes, maintaining membrane fluidity and supporting receptor function, ion channel activity, and neurotransmitter release. It localizes preferentially to the inner leaflet of the plasma membrane via flippase enzymes (P4-ATPases), where it serves as a cofactor for protein kinase C (PKC) isoforms alpha, beta, and gamma — PKC activation phosphorylates substrates including MARCKS and GAP-43, critical for synaptic plasticity and memory consolidation. PS modulates the HPA axis via glucocorticoid receptor feedback, reducing cortisol by 15-30% in stressed individuals. It facilitates choline transport via high-affinity choline transporter (CHT1) into presynaptic terminals, supporting acetylcholine synthesis by choline acetyltransferase. PS also regulates NMDA receptor function and supports Na+/K+-ATPase activity. Downstream, PS enhances CREB phosphorylation and BDNF expression in hippocampal neurons.
Risks & Safety
Noopept
Common
Headache (especially without choline supplementation), irritability at higher doses, brain fog in some users.
Serious
No serious adverse effects documented.
Rare
Emotional blunting at high doses, insomnia, allergic reactions.
Phosphatidylserine
Common
Mild gastrointestinal discomfort, insomnia at high doses.
Serious
May interact with blood thinners.
Rare
Allergic reaction in soy-sensitive individuals (use sunflower-derived).
Full Profiles
Noopept →
A synthetic peptide-derived nootropic often grouped with racetams due to similar effects, though it is technically a dipeptide analog of piracetam. Roughly 1000x more potent by weight than piracetam, requiring only 10-30 mg per dose. It provides both immediate cognitive enhancement and long-term neuroprotective benefits through BDNF and NGF upregulation.
Phosphatidylserine →
A phospholipid that constitutes 15% of the brain's total phospholipid pool and is concentrated in neuronal cell membranes. Phosphatidylserine (PS) supports memory, cognitive function, and cortisol regulation. It is the only nootropic with an FDA-qualified health claim: 'consumption may reduce the risk of cognitive dysfunction in the elderly.' Particularly effective for age-related cognitive decline.